FDA Approves 1st Direct-to-Consumer Genetic Risk Tests

THURSDAY, April 6, 2017 — The U.S. Food and Drug Administration on Thursday approved the first direct-to-consumer genetic health risk tests.
Known as the 23andMe Personal Genome Service Genetic Health Risk tests, they assess a person’s inherited…
Source: Topamax